Reneo Pharmaceuticals Email Format
Biotechnology ResearchCalifornia, United States11-50 Employees
Reneo is a pharmaceutical company historically focused on the development and commercialization of therapies for patients with rare genetic mitochondrial diseases, which are often associated with the inability of mitochondria to produce adenosine triphosphate. For additional information, please see reneopharma.com.